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Imaging Findings
Figure 1 is an axial contrast-enhanced 
T1-weighted MR image of the head 
that was obtained to assess the pa-
tient’s initial report of headache and 
the lesion on the patient’s forehead. 
History A 75-year-old woman with a medical history of gastro-
esophageal reflux disease and type II diabetes presented 
to the hospital with a 3-month history of gradually wors-
ening headaches, vague upper abdominal pain, and lower 
back pain. The patient denied fevers, night sweats, con-
tact with sick individuals, occupational exposure to infec-
tion, bleeding, immunodeficiency, intravenous drug use, 
alcohol or tobacco abuse, history of malignancy, family 
history of genetic disorders, and international travel. 
Physical examination revealed a skin-colored mass pro-
truding from the right side of her forehead, but there 
were no other notable abnormalities. Her diabetes was 
managed with diet, and the only prescription medication 
she was taking was esomeprazole. She was not taking anti-
coagulants. Initial laboratory work-up revealed anemia and 
profound thrombocytopenia (hemoglobin level, 9.4 g/dL; 
platelet count, 16 3 109/L); these were refractory to aggres-
sive treatment, including plasmapheresis, immunosup-
pression with prednisolone, and numerous transfusions. 
Contrast material–enhanced magnetic resonance (MR) 
imaging of the head was performed at admission to fur-
ther evaluate the patient’s headache and the mass on the 
patient’s forehead. Ultrasonography (US) of the abdomen 
was performed to evaluate the cause of abdominal pain. 
The discovery of liver lesions at US led us to perform 
contrast-enhanced computed tomography (CT) of the 
chest, abdomen, and pelvis. Contrast-enhanced MR imag-
ing of the abdomen was performed to narrow the diagnos-
tic considerations for the lesions identified at CT. Bone 
marrow biopsy revealed no evidence of infectious or neo-
plastic processes. Endoscopy and colonoscopy were per-
formed; however, they revealed no abnormalities. Further 
laboratory work-up included extensive testing for para-
sites, fungi, bacteria, and viruses, including the human 
immunodeficiency virus (HIV). All of the results were neg-
ative. On the 17th day of admission, the patient became 
acutely unresponsive, her condition deteriorated rapidly, 
and she died. Unenhanced head CT was performed at the 
time of the patient’s acute decompensation.
There is an extra-axial peripherally en-
hancing soft-tissue lesion extending 
through the diploic space and showing 
mass effect in the right frontal lobe. 
Figure 2 is a transverse gray-scale US 
image of the upper abdomen obtained 
to evaluate the patient’s vague upper 
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is slight heterogeneous enhancement 
of the splenic lesion but no enhance-
ment of the liver lesions. Figure 4b 
shows the pancreas is fatty and atro-
phied, without focal mass. There is no 
renal mass. We identified soft-tissue 
masses in the L1 and L2 vertebral 
bodies on this image. In combination 
with chest CT images, the dynamic 
contrast-enhanced CT images helped 
us exclude the most common malig-
nancies, including those in the breast, 
lung, pancreas, uterus, cervix, ovary, 
and kidney. Endoscopy and colonosco-
py were also performed and revealed 
no mass, which enabled us to virtually 
exclude gastric and colon primary ma-
lignancies. Infectious and neoplastic 
processes were still the major differen-
abdominal pain. This image shows ill-
defined heterogeneous hypoechoic le-
sions, some of which contain internal 
echoes. There is a heterogeneous rim 
surrounding some of the lesions. The 
visualized hepatic parenchyma demon-
strates diffuse heterogeneity. These 
lesions were not suspected clinically 
and shifted the focus to differential di-
agnostic considerations of infectious 
and neoplastic processes; however, 
laboratory tests did not enable us to 
confirm a specific diagnosis. Torso CT 
was performed with intravenous ad-
ministration of contrast material to es-
tablish the distribution of lesions and 
to identify the source. Figure 3 is a 
representative image of the chest ob-
tained through the breasts that shows 
no breast or lung mass. Figure 4a is an 
axial dynamic contrast-enhanced CT 
image obtained in the arterial phase 
that depicts multiple complex low-at-
tenuation lesions throughout the liver. 
A similar large complex low-attenua-
tion lesion is seen in the spleen. There 
Figure 1: Axial T1-weighted (repetition time 
msec/echo time msec, 400/17; 5-mm section 
thickness) contrast-enhanced MR image of the brain 
(10 mL of gadopentetate dimeglumine administered 
intravenously over 15 seconds, Magnevist; Bayer 
Healthcare Pharmaceuticals, Leverkusen, Germany) 
shows a peripherally enhancing soft-tissue lesion 
extending through the diploic space into the paren-
chyma of the right frontal lobe.
Figure 1 
Figure 2: Transverse gray-scale US image of the 
upper abdomen shows ill-defined heterogeneous 
hypoechoic lesions. Some of the lesions contain 
internal echoes, and some have relatively hyper-
echoic rims. The visualized hepatic parenchyma 
demonstrates diffuse heterogeneity.
Figure 2 
Figure 3: Axial contrast-enhanced CT image of 
the chest acquired during the arterial phase (80 mL 
of iohexol 300 administered at a rate of 4 mL/sec, 
Omnipaque 300; GE Healthcare, Milwaukee, Wis). 
There is no lung or breast mass.
Figure 3 
tial considerations; thus, fluorodeoxy-
glucose (FDG) combined positron 
emission tomography (PET) and CT 
were ordered in an to attempt to dis-
tinguish between the two major differ-
ential diagnoses. Figure 5 is the FDG 
PET/CT image, which did not show 
abnormal FDG uptake in the lesions 
and added little information to the 
clinical picture. MR images of the ab-
domen were then obtained to better 
characterize the hepatic and splenic 
lesions. Figure 6 is an ultrafast spin-
echo sequence that reveals a large het-
erogeneous T2 hyperintense lesion in 
the spleen and multiple heterogeneous 
T2 hyperintense lesions throughout 
the liver. Figure 7 was obtained with a 
dynamic postcontrast axial T1-weighted 
Figure 4: Axial contrast-enhanced CT images of 
the liver during the arterial phase (80 mL of iohexol 
300 administered at a rate of 4 mL/sec) show (a) a 
large complex low-attenuation lesion in the spleen 
and multiple complex low-attenuation lesions 
throughout the liver and (b) fatty atrophy of the 
pancreas, without focal mass, and no renal mass.
Figure 4 
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diagnosis, so biopsy was requested. 
Angiosarcoma was not suspected by 
those who performed the procedure. 
Routine CT-guided biopsy of one of the 
liver lesions was attempted, but the re-
sults were nondiagnostic, as the le-
sions yielded only inflammatory cells 
and necrotic tissue. Substantial intra-
peritoneal bleeding was recognized 
several hours after biopsy and required 
multiple transfusions. The patient re-
mained hemodynamically stable; how-
ever, at autopsy several days later, 
there was an estimated 3–4 L of blood 
in the abdomen. Figure 8 is an axial 
CT image of the head without intrave-
nous contrast material obtained at the 
time of the patient’s spontaneous acute 
clinical decompensation several days 
after biopsy. It shows the extra-axial 
mass associated with acute extra-axial 
Figure 5: Representative axial FDG (13.9 mCi, 
infused at a blood glucose level of 113 mg/dL and 
incubated for 62 minutes) PET/CT image through 
the upper abdomen shows low-grade uptake of the 
radiotracer in the periphery of the cystic necrotic 
lesions within the spleen and liver.
Figure 5 
Figure 6: Coronal T2-weighted (900/78, 6-mm 
section thickness) ultrafast spin-echo MR image of 
the abdomen (Symphony; Siemens Medical 
Systems, Erlangen, Germany) shows a large 
complex T2 heterogeneous hyperintense lesion in 
the spleen and multiple heterogeneous T2 hyperin-
tense lesions throughout the liver.
Figure 6 
fat-suppressed gradient-echo sequence, 
and it depicts areas of heterogeneous 
enhancement of the large splenic le-
sion and peripheral enhancement of 
several of the hepatic lesions on the 
early arterial phase image (Fig 7a). 
Figure 7b was obtained in the late ar-
terial phase and shows an additional 
peripherally enhancing lesion in the L1 
vertebral body. The imaging and labo-
ratory results failed to yield a specific 
Figure 7: Axial T1-weighted (4.3/2, 2-mm section 
thickness) dynamic contrast-enhanced ultrafast 
gradient-echo MR images of the abdomen (10 mL 
of gadopentetate dimeglumine) obtained during the 
(a) early and (b) late arterial phases. Images show 
areas of heterogeneous enhancement of the large 
splenic lesion and several of the hepatic lesions (a) 
and an additional peripherally enhancing mass in 
the L1 vertebral body (b).
Figure 7 
Figure 8: Unenhanced axial CT image of the head 
at the time of acute mental status changes and 
clinical deterioiration shows acute subdural and 
epidural hemorrhage causing mass effect in the 
brain and subfalcine herniation.
Figure 8 
hemorrhage and associated mass ef-
fect, including subfalcine herniation. 
Figure 9 is the liver specimen at au-
topsy. It shows parenchymal involve-
ment by ill-defined, hemorrhagic, and 
necrotic foci of angiosarcoma. Figure 10 
is the spleen specimen at autopsy. It 
shows gross organ distortion and in-
volvement by one dominant lesion and 
numerous cystic, necrotic, and hemor-
rhagic lesions that surround the larger 
lesion. Figure 11 is the histologic slice 
of the spleen. It shows an area of hap-
hazard anastomosis of poorly formed 
vascular channels adjacent to an area 
of hemorrhage and necrosis. The vas-
Figure 9: Gross pathologic image of the liver 
shows parenchymal involvement by ill-defined hem-
orrhagic and necrotic foci of angiosarcoma.
Figure 9 
DIAGNOSIS PLEASE: Primary Splenic Angiosarcoma Krol et al
Radiology: Volume 274: Number 1—January 2015 n radiology.rsna.org 301
cular channels are lined by highly pleo-
morphic epithelioid cells of high nu-
clear grade. The autopsy findings of a 
large dominant splenic angiosarcoma 
and multiple smaller foci of angiosar-
coma involving the liver and bones en-
abled us to confirm the diagnosis of 
splenic angiosarcoma.
Discussion
The distribution, behavior, and imaging 
characteristics of the lesions suggest a 
neoplastic or infectious origin. There is 
easily identifiable multifocal disease, 
with one of the lesions extending 
through the skull and compressing the 
right frontal lobe parenchyma. Thus, 
the most likely categories of disease 
processes that would explain these find-
ings are infection and neoplasm.
The major infectious differential con-
siderations for this patient would be ec-
chinococcal infection, bacillary angioma-
tosis, schistosomiasis, and multiple 
abscesses, including those caused by 
amoebic species. Abscesses and bacil-
lary angiomatosis virtually always cause 
high fevers and leukocytosis and are 
therefore unlikely, given this patient’s 
history and laboratory results. Ecchino-
coccal infection was excluded clinically 
with ecchinococcal antigen testing. 
Schistosomiasis represents a reasonable 
differential diagnosis for the liver le-
sions, but it would not explain the soft-
tissue mass in the skull. Other over-
whelmingly rare or atypical infections 
Figure 10: Gross pathologic image of the spleen 
shows a markedly distorted organ with one domi-
nant lesion and numerous surrounding cystic, ne-
crotic, and hemorrhagic lesions.
Figure 10 
Figure 11: Hematoxylin-eosin stained slice of the 
spleen (original magnification, 320) shows an area 
of haphazard anastomosis of poorly formed vascular 
channels adjacent to an area of hemorrhage and 
necrosis. The vascular channels are lined by highly 
pleomorphic epithelioid cells of high nuclear grade.
Figure 11 
were excluded because of the negative 
HIV test results, a lack of immunodefi-
ciency, and a negative history of travel. 
In summary, the lack of signs and symp-
toms of infection and the negative re-
sults of extensive infectious disease test-
ing make an infectious origin unlikely.
An extensive neoplastic process 
would better explain the behavior and 
distribution of the lesions in this patient. 
The most likely cause of multiple he-
patic, splenic, and bone lesions would be 
metastatic disease from a common pri-
mary malignancy, such as the lung, 
breast, pancreas, kidney, or colon. Addi-
tionally, diffuse malignant processes, 
such as lymphoma, leukemia, or mela-
noma, would be a reasonable consider-
ation. Primary breast, renal, lung, pan-
creatic, and gastrointestinal malignancies 
were excluded on the basis of the nor-
mal appearance of these organs at CT, 
other imaging studies, and endoscopy. 
Melanoma is less likely, as it tends to 
appear as T1 shortening on MR images 
from the cellular melanin content and as 
arterial phase enhancement on dynamic 
images (1). The centrally necrotic le-
sions could reasonably represent a com-
mon appearance of melanoma in a pa-
tient undergoing chemotherapy; 
however, this patient never underwent 
treatment for malignancy (2). Leukemia 
and lymphoma will be discussed later in 
this report.
Since metastases from the most 
common malignancies in this case are 
considered unlikely, the differential di-
agnosis for multiple hepatic lesions 
should be expanded to include other, 
more rare processes. Lymphatic mal-
formations and multiple hemangiomas 
could have an appearance similar to 
that of the hepatic and splenic lesions 
seen in this patient, but this would not 
explain the spontaneously hemorrhag-
ing lesion in the skull. Kaposi sarcoma 
is known to involve the liver in patients 
with HIV; however, this patient did not 
have HIV, and primary hepatic or 
splenic Kaposi sarcomas are very rare. 
Epithelioid hemangioendothelioma is 
an important differential diagnosis in 
this case. Epithelioid hemangioendo-
thelioma is often multifocal within the 
liver and can produce similar-appear-
ing lesions at imaging; however, splenic 
and bone metastases are extremely 
rare (3). Primary liver hemangioperi-
cytoma is very rare and may mimic an-
giosarcoma (4). However, it is less 
common than angiosarcoma and pref-
erentially metastasizes to lung and 
bone (5).
There are several primary splenic 
neoplasms that could have imaging 
characteristics similar to those in this 
case. Lymphoma and leukemia could 
explain the distribution of the lesions, 
as well as the anemia and thrombocy-
topenia in this patient. However, these 
are virtually excluded in the setting of 
a negative bone marrow biopsy. Litto-
ral cell angioma produces hypoattenu-
ating splenic lesions and can have ma-
lignant characteristics; however, bone 
metastases are rare in this diagnosis 
(6). Primary splenic hemangiopericy-
toma is a very rare neoplasm that 
mimics splenic angiosarcoma in many 
ways, but it is less common than angio-
sarcoma and tends to metastasize to 
lung and bone (5).
Metastatic splenic angiosarcoma is 
the best diagnosis in this case. The 
spleen is the most likely primary organ 
in this patient for two reasons: First, the 
dominant lesion in the spleen is much 
larger than the metastases elsewhere in 
the body. Second, the pattern of metas-
tasis demonstrated by imaging is most 
consistent with the pattern observed in 
patients with splenic angiosarcoma (7). 
DIAGNOSIS PLEASE: Primary Splenic Angiosarcoma Krol et al
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Primary splenic angiosarcoma is a rare 
aggressive neoplasm with the propensity 
to spontaneously hemorrhage, as dem-
onstrated by this patient’s skull metasta-
sis. These lesions are known to hemor-
rhage significantly after biopsy, which 
was also seen in this patient, who had an 
estimated 3–4 L of blood in her abdo-
men at autopsy. Radiologists should be 
familiar with the appearance of angio-
sarcoma, as well as the potential for ab-
normal platelets with this diagnosis, so 
that they can make informed decisions 
regarding potential biopsy of similar-ap-
pearing lesions. The mean age for 
women to develop splenic angiosarcoma 
is 68 years (8). The most common pre-
senting symptom is vague abdominal 
pain, as in this patient. This pain can be 
acute if there is spontaneous splenic 
rupture. Chest pain, weight loss, and fa-
tigue are other signs and symptoms at 
presentation in a minority of patients. 
The most common laboratory abnormal-
ity is cytopenia, which was seen in up to 
91% of patients in one large study (9). In 
that study, anemia was found in 62% of 
patients, and thrombocytopenia was 
found in up to 33% of patients with a 
diagnosis of angiosarcoma. This patient 
had both of these laboratory abnormal-
ities. In spite of hepatic metastases be-
ing common in the setting of primary 
splenic angiosarcoma, hepatic enzyme 
test results are typically within normal 
limits (8). The most common sites of 
metastases for splenic angiosarcoma are 
liver and bone, specifically the verte-
brae, as in this patient; however, lung 
metastases are not uncommon. Abdom-
inal and mesenteric lymphadenopathy is 
reported less frequently (7). Treatment 
often includes splenectomy and chemo-
therapy, but prognosis is poor and most 
patients die within 1 year of initial diag-
nosis despite treatment (9).
The imaging findings of primary 
splenic angiosarcoma are somewhat 
variable, but certain trends appear to 
exist. The spleen is commonly enlarged, 
measuring more than 12 cm in maxi-
mum dimension. This patient’s spleen 
measured 15.7 cm in maximum dimen-
sion. The majority of patients have dif-
fuse involvement of the spleen either as 
a single large lesion or as a large mass 
with multiple smaller nodules. The le-
sions frequently show central necrosis 
with a rim of soft tissue. At Doppler 
US, the necrotic centers of the lesions 
tend to appear cystic, with internal ech-
oes secondary to debris or hemorrhage, 
while the soft-tissue rim generally ap-
pears heterogeneous in echo texture. 
Typically, on both CT and MR images, 
the primary splenic lesion is poorly de-
fined (60% of cases) and irregularly 
shaped, and it shows irregular hetero-
geneous enhancement on postcontrast 
images (7). On T1-weighted MR im-
ages, the splenic and hepatic lesions 
tend to appear hypointense in the cen-
ter and periphery, with focal areas of 
high signal intensity in the necrotic cen-
ter in some of the lesions. On T2-
weighted MR images, the splenic and 
hepatic lesions appear as ill-defined 
heterogeneously hyperintense lesions 
(7). There has been only one published 
case report in the English literature to 
date of splenic primary angiosarcoma 
imaged with FDG PET/CT, and that 
case showed avid uptake of FDG in the 
neoplasm (10). In the current case, 
FDG PET/CT showed no significant 
avidity for FDG, which is best explained 
by the cystic and necrotic qualities of 
the lesions in this patient (11). This 
case demonstrates the most common 
imaging findings of splenic angiosarco-
ma for US, CT, and MR imaging.
Splenic angiosarcoma is a rare ag-
gressive neoplasm that presents many 
challenges to the clinician and radiolo-
gist. The clinical presentation is often 
nonspecific, and the imaging character-
istics that differentiate angiosarcoma 
from more common diagnoses can be 
subtle. The importance of knowing the 
imaging and clinical features of splenic 
angiosarcoma is most crucial when one 
is considering lesion biopsy. As was 
seen in this patient, this neoplasm is 
known to spontaneously hemorrhage. 
Biopsy will produce hemorrhage, as 
was also seen in this patient, and most 
importantly, there is potential to pro-
duce hemorrhage that is difficult to 
control. Additionally, patients may have 
thrombocytopenia, which can further 
alter the ability to achieve hemostasis 
after the procedure. This knowledge 
will help the physician to choose the 
best technique and location for biopsy 
and to manage potentially catastrophic 
complications.
Acknowledgment: We acknowledge Estill Rob-
inson, BFA, for his contributions to the manu-
script.
Disclosures of Conflicts of Interest: J.J.K. dis-
closed no relevant relationships. V.V.K. dis-
closed no relevant relationships. A.D. disclosed 
no relevant relationships. H.S.G. disclosed no 
relevant relationships.
References
 1.  Hussain SM. Liver MRI: correlation with 
other imaging modalities and histopathology. 
New York, NY: Springer, 2007; 56.
 2.  Blake SP, Weisinger K, Atkins MB, 
Raptopoulos V. Liver metastases from mela-
noma: detection with multiphasic contrast-
enhanced CT. Radiology 1999;213(1):92–96.
 3.  Earnest F 4th, Johnson CD. Case 96: hepatic 
epithelioid hemangioendothelioma. Radiol-
ogy 2006;240(1):295–298.
 4.  Buetow PC, Buck JL, Ros PR, Goodman 
ZD. Malignant vascular tumors of the liver: 
radiologic-pathologic correlation. Radio-
Graphics 1994;14(1):153–166; quiz 167–
168.
 5.  LeGallo RD, Wick MR. Soft tissue. In: 
Gattuso P, Reddy VB, David O, Spitz DJ, 
Haber MH, eds. Differential diagnosis in 
surgical pathology. 2nd ed. Philadelphia, Pa: 
Saunders Elsevier, 2010; 933.
 6.  Levy AD, Abbott RM, Abbondanzo SL. Lit-
toral cell angioma of the spleen: CT features 
with clinicopathologic comparison. Radiol-
ogy 2004;230(2):485–490.
 7.  Thompson WM, Levy AD, Aguilera NS, 
Gorospe L, Abbott RM. Angiosarcoma of the 
spleen: imaging characteristics in 12 patients. 
Radiology 2005;235(1):106–115.
 8.  Neuhauser TS, Derringer GA, Thompson 
LDR, et al. Splenic angiosarcoma: a clinico-
pathologic and immunophenotypic study of 
28 cases. Mod Pathol 2000;13(9):978–987.
 9.  Falk S, Krishnan J, Meis JM. Primary angio-
sarcoma of the spleen. a clinicopathologic 
study of 40 cases. Am J Surg Pathol 1993; 
17(10):959–970.
 10.  Abe T, Sato M, Okumura T, et al. FDG PET/
CT findings of splenic angiosarcoma. Clin 
Nucl Med 2009;34(2):82–83.
 11.  Blake MA, Singh A, Setty BN, et al. Pearls 
and pitfalls in interpretation of abdominal 
and pelvic PET-CT. RadioGraphics 2006; 
26(5):1335–1353.
DIAGNOSIS PLEASE: Primary Splenic Angiosarcoma Krol et al
Radiology: Volume 274: Number 1—January 2015 n radiology.rsna.org 303
Congratulations to the 63 individuals 
and four resident groups that sub-
mitted the most likely diagnosis (me-
tastatic angiosarcoma) for Diagnosis 
Please, Case 213. The names and loca-
tions of the individuals and resident 
groups, as submitted, are as follows: 
Individual responses
Sasha Bhan, Hamilton, Ontario, Canada 
Manon N. Braat, MD, Utrecht, the Netherlands 
Douglas C. Brown, MD, Virginia Beach, Va  
Ian A. Burgess, MD, Manly, New South Wales, 
Australia 
Michael H. Childress, MD, Washington, DC  
Haris Chrysikopoulos, Corfu, Greece, Greece 
Marc G. De Baets, MD, Collina d'Oro, Ticino, 
Switzerland 
Peter de Baets, MD, Damme, Belgium 
Thaworn Dendumrongsup, MD, Songkhla, 
Thailand 
Seyed A. Emamian, MD, PhD, Rockville, Md  
Akira Fujikawa, MD, Tokyo, Japan 
Toshihiro Furuta, MD, PhD, Bunkyo-ku, Tokyo, 
Japan 
Gilles Genin, Annecy, France 
Mark G. Goldshein, MD, Andover, Mass  
Alvaro Gomez Naar, MD, Salta Capital, Salta, 
Argentina 
Wataru Gonoi, MD, PhD, Bunkyo-ku, Tokyo, 
Japan 
Akifumi Hagiwara, MD, Tokyo, Japan 
Stefan Hamelin, MD, Saint Charles, Mo  
Osamu Hasegawa, MD, Koriyama, Fukushima, 
Japan 
D. C. Heasley, Jr, MD, Dallas, Tex  
Noriatsu Ichiba, MD, Otsu, Shiga, Japan 
Takashi Ikeuchi, Moriyama, Shiga, Japan 
Akitoshi Inoue, MD, Otsu, Shiga, Japan 
Shanigarn Keoplung, MD, Muang Nonthaburi, 
Nonthaburi, Thailand 
Patrick Kiely, MBBCh, Limerick, Ireland 
Takao Kiguchi, MD, Niigata, Japan 
Osamu Kizu, MD, Ohtsu, Japan 
Mario A. Laguna, MD, Franklin, Wis  
Matthew L. Levine, MD, Nashua, NH  
Satoshi Matsushima, MD, Tokyo, Japan 
Manabu Minami, MD, PhD, Yokohama, Japan 
Kenichi Mizuki, MD, Hamamatsu-shi, Shizuoka-
ken, Japan 
Toshio Moritani, MD, PhD, Iowa City, Iowa  
Kyoko Nagai, MD, Yokohama, Japan 
Hirotsugu Nakai, MD, Otsu, Shiga, Japan 
Tomokazu Nishiguchi, MD, PhD, Osaka, Japan 
Mizuki Nishino, MD, Boston, Mass  
Hiroshi Nobusawa, MD, PhD, Ota, Tokyo, 
Japan 
Ioannis E. Papachristos, MD, Agrinio, Greece 
Daniel C. Rappaport, MD, Toronto, Ontario, 
Canada 
Mathieu H. Rodallec, MD, Paris, France 
Akihiko Sakata, MD, Kyoto, Japan 
Shuichi Satoh, MD, Oota-ku, Tokyo, Japan 
Pierre Schnyder, MD, La Conversion, 
Switzerland 
Matthew P. Shapiro, MD, Charlottesville, Va  
Hideki Shima, MD, Narita, Chiba, Japan 
Taro Shimono, MD, Osaka, Japan 
Gayathri Sreedher, MBBS, MD, Pittsburgh, Pa  
Hongliang Sun, MD, Beijing, China 
Eliko Tanaka, MD, Yokohama, Japan 
Satoshi Tatsuno, MD, Ichikawa, Chiba, Japan 
Yasuyo Teramura, MD, Tokorozawa, Saitama, 
Japan 
Eugene Tong, MD, Austin, Tex  
Ulysses S. Torres, MD, Sao Paulo, Brazil 
Meric Tuzun, MD, Ankara, Turkey 
Haruo Watanabe, MD, Gifu, Japan 
Tatsuya Yamamoto, MD, Yoshida-gun, Fukui, 
Japan 
Koichiro Yasaka, MD, Tokyo, Japan 
Kurata Yasuhisa, MD, Kobe, Hyogo, Japan 
Hajime Yokota, MD, Kyoto, Japan 
Rika Yoshida, MD, Utsunomiya, Tochigi, Japan 
Kaneko You, Gifu, Japan 
Ahmed Zidan, MD, Barcelona, Spain 
Resident group responses
ICESP Residents, Sao Paulo, Brazil 
Mater Dei Hospital Radiology Residents, Malta
Mie University Hospital Radiology Residents, 
Tsu, Mie, Japan
Prince of Songkla University Radiology 
Residents, Songkla, Thailand
